Literature DB >> 27735824

Comprehensive Complication Index Predicts Cancer-specific Survival After Resection of Colorectal Metastases Independent of RAS Mutational Status.

Suguru Yamashita1, Rahul A Sheth, Andrew S Niekamp, Thomas A Aloia, Yun Shin Chun, Jeffrey E Lee, Jean-Nicolas Vauthey, Claudius Conrad.   

Abstract

OBJECTIVE: To investigate prognostic impact of postoperative complications for colorectal liver metastases (CLM) in the era of RAS mutation analysis.
BACKGROUND: Postoperative complications have been associated with cancer-specific outcomes in multiple malignancies.
METHODS: We identified 575 patients with known RAS mutation status who underwent hepatic resection for CLM during 2008 to 2014. Postoperative complications were scored with the comprehensive complication index (CCI), and the neutrophil-to-lymphocyte ratio (NLR) was used as an indicator of systemic inflammation before and after surgery. Survival after resection of CLM was stratified by CCI (high, ≥26.2; low, <26.2).
RESULTS: Eighty-eight patients had high and 487 low CCI. Recurrence-free survival (RFS) and cancer-specific survival (CSS) after hepatic resection were worse in patients with high CCI than in patients with low CCI (RFS at 3 yrs 26% vs. 41%, P = 0.003; CSS at 5 yrs 46% vs. 64%, P = 0.003). High CCI (odds ratio 3.99, P <0.001) was associated with high NLR (>5) 3 months after hepatic resection. Five factors were associated with worse CSS: high CCI [hazard ratio (HR) 1.61, P = 0.022], primary positive node (HR 1.70, P = 0.003), multiple CLM (HR 1.72, P = 0.001), CLM ≥3 cm (HR 1.73, P <0.001), and mutant RAS (HR 2.04, P <0.001). Receiver operating characteristic and area under receiver operating characteristic curves revealed CCI to be a more sensitive, specific, and accurate predictor of RFS and CSS than NLR.
CONCLUSIONS: High CCI is a potent predictor of worse RFS and CSS after resection of CLM. The ramifications of postsurgical complications extend beyond direct influence on patient outcomes to impact cancer-related survival.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27735824     DOI: 10.1097/SLA.0000000000002018

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  19 in total

1.  The prognostic significance of the comprehensive complication index in patients with gastric cancer.

Authors:  Shota Shimizu; Hiroaki Saito; Yusuke Kono; Yuki Murakami; Yuji Shishido; Kozo Miyatani; Tomoyuki Matsunaga; Yoji Fukumoto; Yoshiyuki Fujiwara
Journal:  Surg Today       Date:  2019-05-30       Impact factor: 2.549

2.  A systematic review and meta-analysis comparing the short- and long-term outcomes for laparoscopic and open liver resections for liver metastases from colorectal cancer.

Authors:  Ruben Ciria; Sira Ocaña; Irene Gomez-Luque; Federica Cipriani; Mark Halls; Åsmund Avdem Fretland; Yukihiro Okuda; Somaiah Aroori; Javier Briceño; Luca Aldrighetti; Bjorn Edwin; Mohammed Abu Hilal
Journal:  Surg Endosc       Date:  2019-04-15       Impact factor: 4.584

3.  Colostomy Reversal following Hartmann's Procedure: The Importance of Timing in Short- and Long-Term Complications: A Retrospective Multicentric Study.

Authors:  Marco Clementi; Renato Pietroletti; Filippo Carletti; Federico Sista; Antonella Grasso; Fabiana Fiasca; Sonia Cappelli; Andrea Balla; Vinicio Rizza; Andrea Ciarrocchi; Stefano Guadagni
Journal:  J Clin Med       Date:  2022-07-28       Impact factor: 4.964

4.  Evaluation of the systemic inflammatory response, endothelial cell dysfunction, and postoperative morbidity in patients, receiving perioperative corticosteroid, developing severe mesenteric traction syndrome - an exploratory study.

Authors:  August Adelsten Olsen; Rune Broni Strandby; Pär Ingemar Johansson; Henrik Sørensen; Lars Bo Svendsen; Michael Patrick Achiam
Journal:  Langenbecks Arch Surg       Date:  2022-04-09       Impact factor: 2.895

5.  Development of a severe mesenteric traction syndrome during major abdominal surgery is associated with increased postoperative morbidity: Secondary data analysis on prospective cohorts.

Authors:  August A Olsen; Rune B Strandby; Nikolaj Nerup; Rikard Ambrus; Jens Peter Gøtze; Lars Bo Svendsen; Michael P Achiam
Journal:  Langenbecks Arch Surg       Date:  2019-12-09       Impact factor: 3.445

6.  Comprehensive Complication Index Predicts Cancer-Specific Survival of Patients with Postoperative Complications after Curative Resection of Gastric Cancer.

Authors:  Ru-Hong Tu; Jian-Xian Lin; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jun Lu; Qi-Yue Chen; Long-Long Cao; Mi Lin; Chao-Hui Zheng; Chang-Ming Huang
Journal:  Gastroenterol Res Pract       Date:  2018-11-19       Impact factor: 2.260

7.  Comprehensive Complication Index Validates Improved Outcomes Over Time Despite Increased Complexity in 3707 Consecutive Hepatectomies.

Authors:  Jordan M Cloyd; Takashi Mizuno; Yoshikuni Kawaguchi; Heather A Lillemoe; Georgios Karagkounis; Kiyohiko Omichi; Yun Shin Chun; Claudius Conrad; Ching-Wei D Tzeng; Bruno C Odisio; Steven Y Huang; Marshall Hicks; Steven H Wei; Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2020-04       Impact factor: 13.787

8.  Renal Dysfunction After Liver Transplantation: Effect of Donor Type.

Authors:  Dagmar Kollmann; Shuet Fong Neong; Roizar Rosales; Bettina E Hansen; Gonzalo Sapisochin; Stuart McCluskey; Mamatha Bhat; Mark S Cattral; Les Lilly; Ian D McGilvray; Anand Ghanekar; David R Grant; Markus Selzner; Florence S H Wong; Nazia Selzner
Journal:  Liver Transpl       Date:  2020-04-23       Impact factor: 5.799

9.  Postoperative survival analysis and prognostic nomogram model for patients with portal hypertension.

Authors:  Ya-Fei Zhang; Hong Ji; Hong-Wei Lu; Le Lu; Lei Wang; Jin-Long Wang; Yi-Ming Li
Journal:  World J Gastroenterol       Date:  2018-10-21       Impact factor: 5.742

10.  Expanding the donor pool: Donation after circulatory death and living liver donation do not compromise the results of liver transplantation.

Authors:  Dagmar Kollmann; Gonzalo Sapisochin; Nicolas Goldaracena; Bettina E Hansen; Ramraj Rajakumar; Nazia Selzner; Mamatha Bhat; Stuart McCluskey; Mark S Cattral; Paul D Greig; Les Lilly; Ian D McGilvray; Anand Ghanekar; David R Grant; Markus Selzner
Journal:  Liver Transpl       Date:  2018-05-14       Impact factor: 5.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.